These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 8770253)
1. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. Tomsick T; Brott T; Barsan W; Broderick J; Haley EC; Spilker J; Khoury J AJNR Am J Neuroradiol; 1996 Jan; 17(1):79-85. PubMed ID: 8770253 [TBL] [Abstract][Full Text] [Related]
2. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Manelfe C; Larrue V; von Kummer R; Bozzao L; Ringleb P; Bastianello S; Iweins F; Lesaffre E Stroke; 1999 Apr; 30(4):769-72. PubMed ID: 10187877 [TBL] [Abstract][Full Text] [Related]
3. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome. Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065 [TBL] [Abstract][Full Text] [Related]
4. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. Kharitonova T; Thorén M; Ahmed N; Wardlaw JM; von Kummer R; Thomassen L; Wahlgren N; J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):273-8. PubMed ID: 18931005 [TBL] [Abstract][Full Text] [Related]
5. Disappearing hyperdense middle cerebral artery sign is associated with striatocapsular infarcts on follow-up CT in ischemic stroke patients treated with intravenous thrombolysis. van Overbeek EC; Knottnerus IL; van Oostenbrugge RJ Cerebrovasc Dis; 2010 Aug; 30(3):285-9. PubMed ID: 20664262 [TBL] [Abstract][Full Text] [Related]
6. Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke. Zou M; Churilov L; He A; Campbell B; Davis SM; Yan B J Clin Neurosci; 2013 Jul; 20(7):984-7. PubMed ID: 23664409 [TBL] [Abstract][Full Text] [Related]
7. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke. Aries MJ; Uyttenboogaart M; Koopman K; Rödiger LA; Vroomen PC; De Keyser J; Luijckx GJ J Neurol Sci; 2009 Oct; 285(1-2):114-7. PubMed ID: 19576595 [TBL] [Abstract][Full Text] [Related]
8. Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis. Forlivesi S; Bovi P; Tomelleri G; Micheletti N; Carletti M; Moretto G; Cappellari M J Thromb Thrombolysis; 2017 Jan; 43(1):86-90. PubMed ID: 27469539 [TBL] [Abstract][Full Text] [Related]
9. Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Kharitonova T; Ahmed N; Thorén M; Wardlaw JM; von Kummer R; Glahn J; Wahlgren N Cerebrovasc Dis; 2009; 27(1):51-9. PubMed ID: 19018138 [TBL] [Abstract][Full Text] [Related]
10. Acute stroke with hyperdense middle cerebral artery sign benefits from IV rtPA. Tartaglia MC; Di Legge S; Saposnik G; Jain V; Chan R; Bussière M; Hachinski V; Frank C; Hesser K; Pelz D Can J Neurol Sci; 2008 Nov; 35(5):583-7. PubMed ID: 19235441 [TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign: A meta-analysis. Sun H; Liu Y; Gong P; Zhang S; Zhou F; Zhou J Acta Neurol Scand; 2020 Mar; 141(3):193-201. PubMed ID: 31598961 [TBL] [Abstract][Full Text] [Related]
12. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420 [TBL] [Abstract][Full Text] [Related]
13. Clot characteristics on computed tomography and response to thrombolysis in acute middle cerebral artery stroke. Topcuoglu MA; Arsava EM; Akpinar E J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1363-72. PubMed ID: 25804568 [TBL] [Abstract][Full Text] [Related]
15. Proximal hyperdense middle cerebral artery sign predicts poor response to thrombolysis. Li Q; Davis S; Mitchell P; Dowling R; Yan B PLoS One; 2014; 9(5):e96123. PubMed ID: 24804962 [TBL] [Abstract][Full Text] [Related]
16. The Hyperdense Middle Cerebral Artery Sign in Drip-and-Ship Models of Acute Stroke Management. Jodaitis L; Ligot N; Chapusette R; Bonnet T; Gaspard N; Naeije G Cerebrovasc Dis Extra; 2020; 10(1):36-43. PubMed ID: 32344421 [TBL] [Abstract][Full Text] [Related]
17. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Mattle HP; Arnold M; Georgiadis D; Baumann C; Nedeltchev K; Benninger D; Remonda L; von Büdingen C; Diana A; Pangalu A; Schroth G; Baumgartner RW Stroke; 2008 Feb; 39(2):379-83. PubMed ID: 18096842 [TBL] [Abstract][Full Text] [Related]
18. Measurement of length of hyperdense MCA sign in acute ischemic stroke predicts disappearance after IV tPA. Shobha N; Bal S; Boyko M; Kroshus E; Menon BK; Bhatia R; Sohn SI; Kumarpillai G; Kosior J; Hill MD; Demchuk AM J Neuroimaging; 2014; 24(1):7-10. PubMed ID: 23316960 [TBL] [Abstract][Full Text] [Related]
19. The utility of middle cerebral artery clot density and burden assessment by noncontrast computed tomography in acute ischemic stroke patients treated with thrombolysis. Topcuoglu MA; Arsava EM; Kursun O; Akpinar E; Erbil B J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e85-91. PubMed ID: 24119367 [TBL] [Abstract][Full Text] [Related]
20. Hyperdense middle cerebral artery sign and response to combination of mechanical Thrombectomy plus intravenous thrombolysis in acute stroke patients. Mowla A; Razavi SM; Lail NS; Mohammadi P; Shirani P; Kavak KS; Sawyer RN; Kamal H J Neurol Sci; 2021 Oct; 429():117618. PubMed ID: 34418800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]